Pharmacists in Traverse City, Michigan


140 Pharmacists found in Traverse City
male pharmacist

Steven Bonkoski, PHARMD


Pharmacist
1105 Sixth St, Traverse City, MI 49684
231-935-5000    

female pharmacist

Mrs. Suzanne Marie Schultz, PHARMACIST


Pharmacist
1105 Sixth St, Traverse City, MI 49684
231-935-5678     231-935-6540

female pharmacist

Mrs. Tera Shawn Kinzel, RPH


Pharmacist
1217 E Front St, Traverse City, MI 49686
231-947-9825     231-947-3102



male pharmacist

Dr. Terry J. Baumann, PHARM.D., BCPS


Pharmacist - Pharmacotherapy
1105 6th St, Munson Medical Center - Department Of Pharmacy, Traverse City, MI 49684
231-935-6589     231-935-5667

male pharmacist

Mr. Thomas James Rice


Pharmacist
1105 Sixth St, Traverse City, MI 49684
231-935-6581    

male pharmacist

Timothy Michael Hamel


Pharmacist
2640 Crossing Cir, Traverse City, MI 49684
231-933-7095     231-933-7097

female pharmacist

Tracy Lynn Haver, R.PH.


Pharmacist
511 S Garfield Ave, Traverse City, MI 49686
231-941-5332    

male pharmacist

Travis Todd Disbrow, RPH


Pharmacist
6288 Galvin Rd, Traverse City, MI 49684
231-943-9870    

male pharmacist

Travis Miller, PHARMD


Pharmacist
626 W Front St, Traverse City, MI 49684
231-935-0185    

male pharmacist

Dr. Victor Chiagoziem Obi


Pharmacist
626 W Front St, Traverse City, MI 49684
231-935-0185    

male pharmacist

Mr. Walter Ronald Kraus, RPH


Pharmacist
1712 S Garfield Ave, Traverse City, MI 49686
231-941-8432     231-941-9152

female pharmacist

Dr. Wendy Kaye Christiani, PHARM.D.


Pharmacist
1105 6th St, Traverse City, MI 49684
231-935-6000    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.